Clinical trial
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in…
NCT00045136 · Poniard Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00045136 |
|---|---|
| Title | Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma |
| Official title | A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma |
| Lead sponsor | Poniard Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | melphalan, peripheral blood stem cell transplantation, holmium Ho 166 DOTMP |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: